Intracystic bleomycin vs other types of intracystic treatment
Total number of adverse effects · cystic craniopharyngiomas in children from birth to 18 years old
It is very uncertain whether intracystic bleomycin changes total number of adverse effects compared with other types of intracystic treatment (very low certainty).
1 finding from 1 review
- Intracystic bleomycin for cystic craniopharyngiomas in children 2016 · Cochrane Headline outcomes onlyRR 1.75 [0.68, 4.53]1 study · 7 participantsVery low